Teva Pharmaceuticals Industries Ltd. has sold its Irvine facilities for what property records indicate to be about $24 million, about a year after the drugmaker decided to permanently shutter the manufacturing site after contamination concerns from the Food and Drug Administration. The sale comes a few months after the $11 billion-valued company (NYSE: TEVA) put […]
Newport Beach Daily News Subscriber Membership Required
You must be a Newport Beach Daily News Subscriber member to access this content.
Already a member? Log in here
